SOLICITATION NOTICE
D -- FY 2019 precisionFDA, Collaborative Omics Environment in the Cloud Indefinite Delivery/ Indefinite Quantity (IDIQ)
- Notice Date
- 8/2/2019
- Notice Type
- Synopsis
- NAICS
- 518210
— Data Processing, Hosting, and Related Services
- Contracting Office
- 4041 Powder Mill Road Beltsville MD 20705
- ZIP Code
- 20705
- Solicitation Number
- FDA-19-SOL-1208859
- Response Due
- 8/17/2019
- Point of Contact
- Laurel A Woest, Contract Specialist, Phone 2404027671, - Steven Gagnon, Contracting Officer , Phone 3017964873
- E-Mail Address
-
laurel.woest@fda.hhs.gov, Steven.Gagnon@fda.hhs.gov
- Small Business Set-Aside
- Total Small Business
- Description
- The Food and Drug Administration (FDA) plays an integral role in precision medicine initiatives, which foresees the day when an individual's medical care will be tailored in part based on their unique characteristics and genetic make-up. To this end, the FDA is developing the tools, standards, and approaches needed to ensure that genomic tests provide reliable and accurate genetic results. This effort is one part of the FDA's commitment to leverage external resources and expertise to advance regulatory science, the science that is essential for product development and evaluation and which underpins the FDA's regulatory decision-making. As part of the FDA's effort to enable innovation in genomic testing, FDA is developing precisionFDA, an open-source, cloud-based regulatory science research space in which community members can share data, ideas and methods that advance the use of next generation sequencing (NGS) technology. precisionFDA provides the community with a research and development system that will enable researchers and developers to test, pilot, and validate existing and new bioinformatics approaches for processing NGS data. NGS test developers, researchers, and other members of the community can share and cross-validate bioinformatics pipelines and results against reference materials that are provided on the precisionFDA system. The beta-release of precisionFDA recently became operational. This IDIQ shall include the maintenance of the current operational system, as well as enhancements to that system through incremental task orders. FDA requires the IT support services of contractors to maintain and improve the production version of precisionFDA system through the following objectives: • Maintain and continue the evolution of the online cloud-based production precisionFDA system that is backed by a FedRAMP moderate compliant genomic platform by providing (1) capabilities to advance genomic sequencing research and develop new NGS methods; and (2) flexibility to be adapted and improved, keeping the pace with the rapidly evolving NGS field. • NGS technologies for the FDA to advance regulatory science and develop regulatory tests. • A system that can expand to support multi-omics scientific capabilities. The current precisionFDA system is already being used to support challenges in addition to genomics (e.g., proteomics). The FDA envisions adding capabilities to support multi-omics sciences as those disciplines become better defined. In order to meet these objectives, the Contractor shall provide a cloud-based genomics platform that has following: • Federal Risk and Authorization Management Program (FedRAMP) Moderate authorization for a cloud-based Platform as a Service (PaaS) • Facilitate private collaborations related to the tools and techniques used to analyze large genomics data sets • Provide the ability to analyze genomics data and test relevant tools and provides a library of reference data and comparative tools • Provide a framework to facilitate genomics scientific community challenges that advances NGS technologies. The Contractor shall deliver all precisionFDA capabilities specified in each task order under this IDIQ. The FDA will provide a list of envisioned capabilities that will evolve as needed throughout the life of the contract; however, a specific set of capabilities will be assigned to each task order. The Contractor shall ensure that any part of the solution that uses cloud services continues to meet a FedRAMP moderate authorization. The contractor shall ensure that the overall precisionFDA system continues to achieve a Federal Information Security Management Act (FISMA) moderate certification. Task Areas that may be awarded through task orders from the IDIQ shall include Project Management, Increment Development, Operations and Maintenance, User Support, and Transition In and Out activities. Unless otherwise specified at the task order level, the Contractor shall perform at the Contractor facility. The Contractor shall report to FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD 20993, for periodic review meetings and other meetings as required on individual task orders. All responsible sources may submit a proposal which shall be considered by the agency. All interested vendors must be registered in SAM (www.sam.gov) for contract award, and shall have completed their Representations and Certifications completed. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (02-AUG-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-19-SOL-1208859/listing.html)
- Place of Performance
- Address: Unless otherwise specified at the task order level, the Contractor shall perform at the Contractor facility. The Contractor shall report to FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD 20993, for periodic review meetings and other meetings as required on individual task orders. Silver Spring, MD
- Zip Code: 20993
- Country: US
- Zip Code: 20993
- Record
- SN05390668-F 20190804/190802230011 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |